Isracann Biosciences Inc (ISCNF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Isracann Biosciences Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2022 | -0.1266M |
| May 31, 2022 | -0.1812M |
| February 28, 2022 | -0.40M |
| November 30, 2021 | -0.4547M |
| August 31, 2021 | -0.3555M |
| May 31, 2021 | -0.817M |
| February 28, 2021 | -0.8041M |
| November 30, 2020 | -0.9861M |
| August 31, 2020 | -0.6626M |
| May 31, 2020 | -0.8548M |
| February 29, 2020 | -2.899M |
| November 30, 2019 | -3.266M |
| August 31, 2019 | -1.128M |
| May 31, 2019 | 1.056M |
| February 28, 2019 | -0.506M |
| November 30, 2018 | -1.554M |
| August 31, 2018 | -1.374M |
| May 31, 2018 | -1.491M |
| February 28, 2018 | -2.870M |
| November 30, 2017 | -2.602M |
| August 31, 2017 | -0.053M |
| May 31, 2017 | -0.1083M |
| February 28, 2017 | -0.0141M |
| November 30, 2016 | -0.0372M |
| August 31, 2016 | -0.2686M |
| Date | Value |
|---|---|
| May 31, 2016 | 0.0021M |
| February 29, 2016 | -0.0264M |
| November 30, 2015 | -0.1187M |
| August 31, 2015 | 0.0194M |
| May 31, 2015 | -0.0419M |
| February 28, 2015 | -0.0783M |
| November 30, 2014 | -0.2508M |
| August 31, 2014 | -0.2762M |
| May 31, 2014 | -0.0233M |
| February 28, 2014 | -0.0131M |
| November 30, 2013 | -0.026M |
| August 31, 2013 | -0.0209M |
| May 31, 2013 | -0.0061M |
| February 28, 2013 | -0.0187M |
| November 30, 2012 | -0.0358M |
| August 31, 2012 | -0.0264M |
| May 31, 2012 | -0.0188M |
| February 29, 2012 | -0.0222M |
| November 30, 2011 | -0.0415M |
| August 31, 2011 | 0.0181M |
| May 31, 2011 | -0.0069M |
| February 28, 2011 | -0.0249M |
| November 30, 2010 | -0.0875M |
| August 31, 2010 | -0.0246M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.266M
Minimum
Nov 2019
1.056M
Maximum
May 2019
-0.8486M
Average
-0.7333M
Median
Free Cash Flow (Quarterly) Benchmarks
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.25M |
| Edesa Biotech Inc | -1.406M |
| Lexaria Bioscience Corp | -0.6766M |
| Liminal Biosciences Inc (DELISTED) | -5.827M |